Previous close | 24.10 |
Open | 24.04 |
Bid | 23.42 x 600 |
Ask | 23.48 x 200 |
Day's range | 23.44 - 25.47 |
52-week range | 16.95 - 49.50 |
Volume | |
Avg. volume | 1,515,841 |
Market cap | 1.932B |
Beta (5Y monthly) | 1.77 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.72 |
Earnings date | 08 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 50.00 |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Gene editing is one of the most exciting and interesting investment opportunities. So, here are two stocks to consider buying in the space. The post 2 stocks to buy in the high potential gene editing space appeared first on The Motley Fool UK.
Beam Therapeutics (BEAM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.